ADNP and breast cancer: To further study the possible molecular mechanism why ADNP regulated EMT and cisplatin-resistance, we treated the BC cells with cisplatin (0.125 ug/ml, 48 h) and used western bolt to explore the protein expression of the key proteins in the TGF-β/Smad, which is classic signaling pathway in EMT processes.